Ronald W. Pero

Direttore Tecnico/Scientifico/R&S presso RezGen5 Ltd.

Health Technology

Consumer Services

Profilo

Ronald W.
Pero is a Professor-Emeritus at the University of Lund.
He is also the Chief Scientific Officer at RezGen5 Ltd.
and a Founding Member of Campamed, Inc. and Deep South Partners LLC.
Previously, he was a Founding Member of Oncotelic Therapeutics, Inc. and Optigenex, Inc.

Posizioni attive di Ronald W. Pero

Società	Posizione	Inizio
RezGen5 Ltd. RezGen5 Ltd. Pharmaceuticals: MajorHealth Technology RezGen5 Ltd. operates as a biopharmaceutical company, which focused on discovering and developing proprietary, orally available, small molecule drugs with the potential to treat diseases associated with ageing, including metabolic diseases such as Type 2 Diabetes, Alzheimer's and cardiovascular diseases. The company was founded by Stuart Garret on June 15, 2012 and is headquartered in Hamilton, Bermuda.	Direttore Tecnico/Scientifico/R&S	-
University of Lund	Corporate Officer/Principal	-
Campamed, Inc.	Corporate Officer/Principal	-
Deep South Partners LLC	Corporate Officer/Principal	-

Tutte le posizioni attive di Ronald W. Pero

Precedenti posizioni note di Ronald W. Pero

Società	Posizione	Fine
OPTIGENEX INC.	Corporate Officer/Principal	-
ONCOTELIC THERAPEUTICS, INC.	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Ronald W. Pero

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Ronald W. Pero

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	2
ONCOTELIC THERAPEUTICS, INC.	Health Technology
OPTIGENEX INC.	Health Technology

Aziende private	3
RezGen5 Ltd. RezGen5 Ltd. Pharmaceuticals: MajorHealth Technology RezGen5 Ltd. operates as a biopharmaceutical company, which focused on discovering and developing proprietary, orally available, small molecule drugs with the potential to treat diseases associated with ageing, including metabolic diseases such as Type 2 Diabetes, Alzheimer's and cardiovascular diseases. The company was founded by Stuart Garret on June 15, 2012 and is headquartered in Hamilton, Bermuda.	Health Technology
Campamed, Inc.
Deep South Partners LLC

Vedi le connessioni aziendali

Borsa valori
Insiders
Ronald W. Pero